China Pharma Holdings (CPHI) Reports In-Line Q2 EPS

China Pharma Holdings (NYSE: CPHI) reported Q2 EPS of $0.11, in-line with the analyst estimate of $0.11. Revenue for the quarter came in at $19.6 million versus the consensus estimate of $19.46 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• The Gap, Inc. (GAP) Tops Q2 EPS by 3c
• Dollar General (DG) Tops Q2 EPS by 48c, Beats on Revenue; Offers FY27 EPS Guidance
• HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance